Global healthcare major Johnson & Johnson (NYSE:JNJ) has reached a $204.9 million settlement over its two pelvic mesh implant class action lawsuits in Australia.
The lawsuits were filed by Shine Lawyers over the company’s sale of defective implants to women in the country. According to Shine, this was the largest product-liability class action settlement in Australia and involved over 11,000 claimants.
J&J has also seen lawsuits in the U.S., Canada, and Europe similar to Shine’s and according to Inquirer, total settlements involving pelvic mesh manufacturers have been upwards of $8 billion.
While the settlement is subject to federal approval, a federal court judge in Australia had earlier found that the company had made the sales of implants without risk warnings and had brought the product to market sans proper testing.
Read full Disclosure
